Table 7 Top 15 significantly different metabolites between control and SIRS groups.
Metabolites | t.stat | P.value | VIP |
---|---|---|---|
4-[4-phenyl-5-(trifluoromethyl)-3-thienyl]thiomorpholine-3,5-dione | −46.185 | 1.76E-63 | 2.0489 |
2-[(2-chlorobenzyl)sulfanyl]-4,6-dimethylnicotinonitrile | −46.037 | 2.31E-63 | 2.0486 |
Phe-Phe | 42.115 | 4.17E-60 | 2.0407 |
N1-[2-(1 H-indol-3-yl)ethyl]-3,4-dichlorobenzene-1-sulfonamide | −42.001 | 5.23E-60 | 2.0405 |
4-(tert-butyl)-3-(4-chlorophenethyl)-2,3-dihydro-1,3-thiazole-2-thione | −41.798 | 7.86E-60 | 2.04 |
Ne-(1-Carboxymethyl)-L-lysine | −41.124 | 3.07E-59 | 2.0384 |
RMK | 40.519 | 1.06E-58 | 2.0369 |
6-bromo-3-(2-phenylethanhydrazonoyl)-2 H-chromen-2-one | −39.706 | 5.76E-58 | 2.0347 |
3-(2,3-dihydro-1 H-indol-1-yl)-2-[(2-furylmethyl)sulfonyl]acrylonitrile | −39.171 | 1.78E-57 | 2.0333 |
Ala-Gln | −38.221 | 1.37E-56 | 2.0305 |
N1-(2,4-dimethylphenyl)-2-(2,4-dichlorophenoxy)propanamide | −37.959 | 2.43E-56 | 2.0297 |
Hydroxykynurenine | −37.911 | 2.70E-56 | 2.0295 |
N-Methyl (-)Ephedrine | 37.455 | 7.37E-56 | 2.0281 |
Methyl 2-(acetylamino)-4-amino-4-oxobutanoate | −36.991 | 2.07E-55 | 2.0266 |
Enrofloxacin | 36.853 | 2.81E-55 | 2.0261 |